'US industry reviewing SC decision on Novartis'

The US industry said on Wednesday it is reviewing the order of the Supreme Court early this week that denied patent on Glivec, a cancer medication produced by Swiss drug maker Novartis, as......

Domestic pharma lauds apex court verdict

Though the India office here of Swiss pharma giant Novartis  wore a gloomy look following the Supreme Court rejection of its Glivec patent application, Indian pharmaceutical companies and......

Drug pricing: Govt decides to bypass three patents

The government's move to issue compulsory licences for three more patented cancer drugs is a jolt to multinational pharmaceutical companies.The plan is to issue CLs for Trastuzumab (or Herceptin,......

Obama: A new era of regulation

At offices of the Environmental Protection Agency in Washington, some staffers are planning Inauguration parties. Their excitement is a harbinger of the sweeping changes in business regulation......